Page last updated: 2024-08-17

bromodeoxyuridine and Kaposi Sarcoma

bromodeoxyuridine has been researched along with Kaposi Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrei, G; Boelaert, JR; De Clercq, E; Degraef, C; Heenen, M; Hermans, P; Noel, JC; Simonart, T; Snoeck, R; van den Oord, JJ; Van Vooren, JP	1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Kaposi Sarcoma

Article	Year
Desferrioxamine enhances AIDS-associated Kaposi's sarcoma tumor development in a xenograft model. International journal of cancer, 2002, Jul-10, Volume: 100, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Animals; Apoptosis; Body Weight; Bromodeoxyuridine; Cell Division; Deferoxamine; Humans; In Situ Nick-End Labeling; Iron; Iron Chelating Agents; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Sarcoma, Kaposi; Transplantation, Heterologous; Tumor Cells, Cultured	2002

Article

Year

Desferrioxamine enhances AIDS-associated Kaposi's sarcoma tumor development in a xenograft model.

International journal of cancer, 2002, Jul-10, Volume: 100, Issue:2

Topics: Acquired Immunodeficiency Syndrome; Animals; Apoptosis; Body Weight; Bromodeoxyuridine; Cell Division; Deferoxamine; Humans; In Situ Nick-End Labeling; Iron; Iron Chelating Agents; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Sarcoma, Kaposi; Transplantation, Heterologous; Tumor Cells, Cultured

2002